Mechanisms of progression of chronic kidney disease
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Chronic kidney disease (CKD) occurs in all age groups, including children. Regardless of the underlying cause, CKD is characterized by progressive scarring that ultimately affects all structures of the kidney. The relentless progression of CKD is postulated to result from a self-perpetuating vicious cycle of fibrosis activated after initial injury. We will review possible mechanisms of progressive renal damage, including systemic and glomerular hypertension, various cytokines and growth factors, with special emphasis on the renin–angiotensin–aldosterone system (RAAS), podocyte loss, dyslipidemia and proteinuria. We will also discuss possible specific mechanisms of tubulointerstitial fibrosis that are not dependent on glomerulosclerosis, and possible underlying predispositions for CKD, such as genetic factors and low nephron number.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
RetractedThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES
BARKER, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91340-1 · Cited by 2,892 · cited 1×
“The link is postulated to be due to the decreased nephron number that accompanies low term birth weight, defined as less than 2,500 g [117, 118].”
BackgroundEpstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,075
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation
Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., & Brenner, B. M. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.241.1.f85 · Cited by 1,680
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Glomeruli and Blood Pressure: Less of One, More the Other?
Brenner, B. M., Garcia, D. L., & Anderson, S. (1988) · American Journal of Hypertension · doi:10.1093/ajh/1.4.335 · Cited by 1,301
Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis
Kaplan, J. M., H Kim, S., North, K. N., Rennke, H., A Correia, L., Tong, H.-Q., Mathis, B. J., Rodríguez-Pérez, J.-C., Allen, P. G., Beggs, A. H., et al. (2000) · Nature Genetics · doi:10.1038/73456 · Cited by 1,235
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,037
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Culpin, M. (1934) · The Lancet · Cited by 971
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Congenital Nephrotic Syndrome in Mice Lacking CD2-Associated Protein
Shih, N.-Y., Li, J., Karpitskii, V., Nguyen, A., Dustin, M. L., Kanagawa, O., Miner, J. H., & Shaw, A. S. (1999) · Science · doi:10.1126/science.286.5438.312 · Cited by 861
The podocyte’s response to injury: role in proteinuria and glomerulosclerosis
Shankland, S. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000410 · Cited by 846
How Does Proteinuria Cause Progressive Renal Damage?
Abbate, M., Zoja, C., & Remuzzi, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040377 · Cited by 779
Nephrin is specifically located at the slit diaphragm of glomerular podocytes
Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestilä, M., Jalanko, H., Holmberg, C., & Tryggvason, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7962 · Cited by 767
Wharram, B. L., Goyal, M., Wiggins, J. E., Sanden, S. K., Hussain, S., Filipiak, W. E., Saunders, T. L., Dysko, R. C., Kohno, K., Holzman, L. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010055 · Cited by 737
Brenner, R. J., Spring, D. B., Sebastian, A., McSherry, E. M., Genant, H. K., Palubinskas, A. J., & Morris, R. C. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070403 · Cited by 700
Angiotensin II type 2 receptor mediates programmed cell death.
Yamada, T., Horiuchi, M., & Dzau, V. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.156 · Cited by 697
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Apoptosis in podocytes induced by TGF-β and Smad7
Schiffer, M., Bitzer, M., Roberts, I. S. D., Kopp, J. B., ten Dijke, P., Mundel, P., & Böttinger, E. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12367 · Cited by 598
Kasiske, B. L., Kalil, R. S. N., Ma, J. Z., Liao, M., & Keane, W. F. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00009 · Cited by 594
Progression of glomerular diseases: Is the podocyte the culprit?
Kriz, W., Gretz, N., & Lemley, K. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00044.x · Cited by 592
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Role of the Microvascular Endothelium in Progressive Renal Disease
Kang, D.-H., Kanellis, J., Hugo, C., Truong, L., Anderson, S., Kerjaschki, D., Schreiner, G. F., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133806 · Cited by 466
A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats.
Shimamura, T., & Morrison, A. B. (1975) · PubMed · Cited by 449
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Böttinger, E. P., Klotman, P. E., & Thorgeirsson, S. S. (1996) · PubMed · Cited by 422
Ruf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
Remuzzi, G., & Bertani, T. (1990) · Kidney International · doi:10.1038/ki.1990.217 · Cited by 397
Racial Differences in Low Birth Weight
Kleinman, J. C., & Kessel, S. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171207 · Cited by 373
Johnson, R. J., Raines, E. W., Floege, J., Yoshimura, A., Pritzl, P., Alpers, C., & Ross, R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1413 · Cited by 341
Bianchi, S., Bigazzi, R., & Campese, V. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001854 · Cited by 338
Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119321 · Cited by 326
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events
Wang, Y., Wang, Y. P., Tay, Y.-C., & Harris, D. C. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00342.x · Cited by 326
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 320
Ishidoya, S., Morrissey, J., McCracken, R., Reyes, A., & Klahr, S. (1995) · Kidney International · doi:10.1038/ki.1995.183 · Cited by 319
Angiotensin II as a renal growth factor.
Wolf, G., & Neilson, E. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391531 · Cited by 307
Tonelli, M., Moyé, L., Sacks, F. M., Cole, T., & Curhan, G. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068461.45784.2f · Cited by 306
The Early Natural History of Nephropathy in Type 1 Diabetes
Drummond, K., Mauer, M., & for the International Diabetic Nephropathy Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1580 · Cited by 303
Induction of TRPC6 Channel in Acquired Forms of Proteinuric Kidney Disease
Mo[Combining Diaeresis]ller, C. C., Wei, C., Altintas, M. M., Li, J., Greka, A., Ohse, T., Pippin, J. W., Rastaldi, M. P., Wawersik, S., Schiavi, S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091010 · Cited by 299
Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy
Qi, Z., Fujita, H., Jin, J., Davis, L. S., Wang, Y., Fogo, A. B., & Breyer, M. D. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2628 · Cited by 297
Self-citationPeroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 295
Wolf, G., & Ritz, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00145.x · Cited by 289
Hoy, W. E., Hughson, M. D., Singh, G. R., Douglas-Denton, R., & Bertram, J. F. (2006) · Kidney International · doi:10.1038/sj.ki.5000397 · Cited by 260
The AT2 receptor—A matter of love and hate
Steckelings, U. M., Kaschina, E., & Unger, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.010 · Cited by 257
Al-Awqati, Q., & Oliver, J. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00164.x · Cited by 257
Renin inhibition with aliskiren: where are we now, and where are we going?
Azizi, M., Webb, R., Nussberger, J., & Hollenberg, N. K. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202812.72341.99 · Cited by 253
Novel Mutations in NPHS2 Detected in Both Familial and Sporadic Steroid-Resistant Nephrotic Syndrome
Karle, S. M., Uetz, B., Ronner, V., Glaeser, L., Hildebrandt, F., & Fuchshuber, A. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132388 · Cited by 248
Ohkubo, N., Matsubara, H., Nozawa, Y., Mori, Y., Murasawa, S., Kijima, K., Maruyama, K., Masaki, H., Tsutumi, Y., Shibazaki, Y., et al. (1997) · Circulation · doi:10.1161/01.cir.96.11.3954 · Cited by 246
MacKinnon, M., Shurraw, S., Akbari, A., Knoll, G. A., Jaffey, J., & Clark, H. D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.077 · Cited by 246
Model of robust induction of glomerulosclerosis in mice: Importance of genetic background
Ma, L.-J., & Fogo, A. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00058.x · Cited by 246
Self-citationRusso, D., Pisani, A., Balletta, M. M., De Nicola, L., Savino, F. A., Andreucci, M., & Minutolo, R. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70416-6 · Cited by 243
Matsusaka, T., Xin, J., Niwa, S., Kobayashi, K., Akatsuka, A., Hashizume, H., Wang, Q.-C., Pastan, I., Fogo, A. B., & Ichikawa, I. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080720 · Cited by 242
Self-citationRenal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Hypertension · doi:10.1161/hy0102.100536 · Cited by 230
Immune dysregulation in TGF- beta 1-deficient mice.
Christ, M., McCartney-Francis, N. L., Kulkarni, A. B., Ward, J. M., Mizel, D. E., Mackall, C. L., Gress, R. E., Hines, K. L., Tian, H., Karlsson, S., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1936 · Cited by 229
Austin, H. A., Boumpas, D. T., Vaughan, E. M., & Balow, J. E. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.9.1620 · Cited by 229
The slit diaphragm: a signaling platform to regulate podocyte function
Huber, T. B., & Benzing, T. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165885.85803.a8 · Cited by 227
Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action
Eddy, A. A., & Fogo, A. B. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050503 · Cited by 222
Self-citationMa, L.-J., Yang, H., Gaspert, A., Carlesso, G., Barty, M. M., Davidson, J. M., Sheppard, D., & Fogo, A. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63486-4 · Cited by 215
Self-citationTime to abandon microalbuminuria?
Ruggenenti, P., & Remuzzi, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001729 · Cited by 213
Dyslipidemia and the progression of renal disease in chronic renal failure patients
Cases, A., & Coll, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09916.x · Cited by 211
Cloning of rat nephrin: Expression in developing glomeruli and in proteinuric states
Kawachi, H., Koike, H., Kurihara, H., Yaoita, E., Orikasa, M., Shia, M. A., Sakai, T., Yamamoto, T., Salant, D. J., & Shimizu, F. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00044.x · Cited by 209
Buckingham, R. E., Al-Barazanji, K. A., Toseland, C. D. N., Slaughter, M., Connor, S. C., West, A., Bond, B., Turner, N. C., & Clapham, J. C. (1998) · Diabetes · doi:10.2337/diab.47.8.1326 · Cited by 203
Kon, V., Fogo, A., Ichikawa, I., Hellings, S. E., & Bills, T. (1993) · Kidney International · doi:10.1038/ki.1993.279 · Cited by 200
Self-citationMechanisms of Disease: fibroblasts—a new look at an old problem
Neilson, E. G. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0093 · Cited by 200
Oikawa, T., Freeman, M., Lo, W., Vaughan, D. E., & Fogo, A. (1997) · Kidney International · doi:10.1038/ki.1997.20 · Cited by 194
Self-citationThe role of VEGF-A in glomerular development and function
Eremina, V., & Quaggin, S. E. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200401000-00002 · Cited by 194
Ma, L.-J., Marcantoni, C., Linton, M. F., Fazio, S., & Fogo, A. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051899.x · Cited by 191
Self-citationHunley, T. E., Julian, B. A., Phillips, J. A., Summar, M. L., Yoshida, H., Horn, R. G., Brown, N. J., Fogo, A., Ichikawa, I., & Kon, V. (1996) · Kidney International · doi:10.1038/ki.1996.81 · Cited by 191
Self-citationAngiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
Yoshida, H., Kuriyama, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, A., Kubo, H., Kawaguchi, Y., Kon, V., Matsuoka, K., et al. (1996) · Kidney International · doi:10.1038/ki.1996.362 · Cited by 189
Brown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., & Vaughan, D. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6305 · Cited by 182
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
Nakamura, S., Nakamura, I., Ma, L., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00160.x · Cited by 178
Self-citationRegression of Existing Glomerulosclerosis by Inhibition of Aldosterone
Aldigier, J. C., Kanjanbuch, T., Ma, L.-J., Brown, N. J., & Fogo, A. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090804 · Cited by 171
Self-citationMa, J., Nishimura, H., Fogo, A., Kon, V., Inagami, T., & Ichikawa, I. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00893.x · Cited by 168
Self-citationThe pathobiology of the mesangium
Kashgarian, M., & Sterzel, R. B. (1992) · Kidney International · doi:10.1038/ki.1992.74 · Cited by 162
Kakinuma, Y., Kawamura, T., Bills, T., Yoshioka, T., Ichikawa, I., & Fogo, A. (1992) · Kidney International · doi:10.1038/ki.1992.259 · Cited by 159
Self-citationKetteler, M., Noble, N. A., & Border, W. A. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.001431 · Cited by 151
Recent advances in statins and the kidney
Oda, H., & Keane, W. F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07101.x · Cited by 150
Nath, K. A., Kren, S. M., & Hostetter, T. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112703 · Cited by 148
Regression of IgA nephropathy: A repeat biopsy study
Hotta, O., Furuta, T., Chiba, S., Tomioka, S., & Taguma, Y. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31399 · Cited by 148
Ma, L., Nakamura, S., Aldigier, J., Rossini, M., Yang, H., Liang, X., Nakamura, I., Marcantoni, C., & Fogo, A. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060492 · Cited by 147
Self-citationWu, D. T., Bitzer, M., Ju, W., Mundel, P. H., & Diaeresisttinger, E. P. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121055 · Cited by 146
Ots, M., Mackenzie, H. S., Troy, J. L., Rennke, H. G., & Brenner, B. M. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v92224 · Cited by 146
Benigni, A., Tomasoni, S., Gagliardini, E., Zoja, C., Grunkemeyer, J. A., Kalluri, R., & Remuzzi, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125941 · Cited by 145
The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
Nyengaard, J. R., & Rasch, R. (1993) · Diabetologia · doi:10.1007/bf00399948 · Cited by 140
Nishida, M., Fujinaka, H., Matsusaka, T., Price, J. O., Kon, V., Fogo, A. B., Davidson, J. M., Linton, M. F., Fazio, S., Homma, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15045 · Cited by 139
Self-citationHyperlipidemia and progressive renal disease.
Keane, W. F., Mulcahy, W. S., Kasiske, B. L., Kim, Y., & Mp, O. (1991) · PubMed · Cited by 132
The lack of a functional p21 WAF1/CIP1 gene ameliorates progression to chronic renal failure
Megyesi, J., Price, P. M., Tamayo, E., & Safirstein, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10830 · Cited by 125
Mucha, B. E., Özaltın, F., Hinkes, B. G., Hasselbacher, K., Ruf, R. G., Schultheiß, M., Hangan, D., Hoskins, B. E., Everding, A. S., Bogdanović, R., et al. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000196717.94518.f0 · Cited by 119
Aldosterone Blockade: An Emerging Strategy for Abrogating Progressive Renal Disease
Epstein, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.038 · Cited by 119
Proteomic Patterns and Prediction of Glomerulosclerosis and Its Mechanisms
Xu, B. J., Shyr, Y., Liang, X., Ma, L.-J., Donnert, E., Roberts, J. D., Zhang, X., Kon, V., Brown, N. J., Caprioli, R. M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030262 · Cited by 112
Self-citationCombination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy
Hebert, L. A., Falkenhain, M. E., Nahman, N. S., Cosio, F. G., & O’Dorisio, T. M. (1999) · American Journal of Nephrology · doi:10.1159/000013417 · Cited by 110
Nonimmunologic Mechanisms of Glomerular Injury
Olson, J. L., & Heptinstall, R. H. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4502-5_9 · Cited by 108
Grond, J., Weening, J. J., & Elema, J. D. (1984) · PubMed · Cited by 107
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 99
Self-citationIchikawa, I., Ma, J., Motojima, M., & Matsusaka, T. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165884.85803.e1 · Cited by 97
Number and dimensions of rat glomerular capillaries in normal development and after nephrectomy
Nyengaard, J. R. (1993) · Kidney International · doi:10.1038/ki.1993.147 · Cited by 97
Forbes, J. M., Bonnet, F., Russo, L. M., Burns, W. C., Cao, Z., Candido, R., Kawachi, H., Allen, T. J., Cooper, M. E., Jerums, G., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00034 · Cited by 90
Ma, L.-J., Jha, S. S., Ling, H., Pozzi, A., Ledbetter, S., & Fogo, A. B. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00381.x · Cited by 90
Self-citationKatz, A., Caramori, M. L., Sisson-Ross, S., Groppoli, T. J., Basgen, J. M., & Mauer, M. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00370.x · Cited by 89
Angiotensin II, TGF-β and Renal Fibrosis
Gaedeke, J., Peters, H., Noble, N. A., & Border, W. A. (2001) · KARGER eBooks · doi:10.1159/000060162 · Cited by 84
Polymorphisms of the renin-angiotensin system genes in progressive renal diseases
Yoshida, H., Kon, V., & Ichikawa, I. (1996) · Kidney International · doi:10.1038/ki.1996.371 · Cited by 82
Expression of the cyclin kinase inhibitor, p27kip, in developing and mature human kidney
Combs, H. L., Shankland, S. J., Setzer, S. V., Hudkins, K. L., & Alpers, C. E. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00842.x · Cited by 68
Combination ACEI and ARB therapy: additional benefit in renoprotection?
Taal, M. W., & Brenner, B. M. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00001 · Cited by 66
Hashimoto, N., Maeshima, Y., Satoh, M., Odawara, M., Sugiyama, H., Kashihara, N., Matsubara, H., Yamasaki, Y., & Makino, H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00294.2003 · Cited by 62
Cell Cycle Regulatory Proteins in Glomerular Disease
Shankland, S. J., & Al-Douahji, M. (1999) · Nephron Experimental Nephrology · doi:10.1159/000020603 · Cited by 58
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications?
Winn, M. P., Daskalakis, N., Spurney, R. F., & Middleton, J. P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090962 · Cited by 54
Cell cycle regulatory proteins in glomerular disease
Shankland, S. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00709.x · Cited by 52
Chronic renal failure in infants and children
Foreman, J. W., & Chan, J. C. M. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80003-9 · Cited by 47
Gbadegesin, R., Hinkes, B. G., Vlangos, C. N., Mucha, B. E., Liu, J., Hopcian, J. T., & Hildebrandt, F. (2007) · Pediatric Nephrology · doi:10.1007/s00467-006-0377-y · Cited by 37
August, P., Leventhal, B., & Suthanthiran, M. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0080-5 · Cited by 29
Molecular approaches to chronic kidney disease
Schmid, H., Henger, A., & Kretzler, M. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000214770.11609.fb · Cited by 24
ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN DISORDERS OF THE URINARY TRACT
Brock, J. W. I., Hunley, T. E., Adams, M. C., & Kon, V. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62423-6 · Cited by 21
Boonstra, A. H., de Zeeuw, D., de Jong, P. E., & Navis, G. J. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.26804 · Cited by 13
Cited by
Ju, W., Nair, V., Smith, S., Zhu, L., Shedden, K., Song, P. X. K., Mariani, L. H., Eichinger, F. H., Berthier, C. C., Randolph, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7071 · Cited by 426
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Jefferson, J. A., Shankland, S. J., & Pichler, R. H. (2008) · Kidney International · doi:10.1038/ki.2008.128 · Cited by 419
Causes and pathogenesis of focal segmental glomerulosclerosis
Fogo, A. B. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.216 · Cited by 360
Self-citationIdentification of adult nephron progenitors capable of kidney regeneration in zebrafish
Diep, C. Q., Ma, D., Deo, R. C., Holm, T. M., Naylor, R. W., Arora, N., Wingert, R. A., Bollig, F., Djordjevic, G., Lichman, B., et al. (2011) · Nature · doi:10.1038/nature09669 · Cited by 308
Semedo, P., Correa-Costa, M., Antonio Cenedeze, M., Maria Avancini Costa Malheiros, D., Antonia dos Reis, M., Shimizu, M. H., Seguro, A. C., Pacheco-Silva, A., & Saraiva Ĉamara, N. O. (2009) · Stem Cells · doi:10.1002/stem.214 · Cited by 295
Metadata
- Authors
- Fogo, A. B.
- Venue
- Pediatric Nephrology
- Published
- 2007-07-24
- Volume
- 22
- Issue
- 12
- Pages
- 2011-2022
- ISSN
- 0931-041X (ISSN-L)
- 1432-198X
- OpenAlex
- W2162024627
- Cited by
- 263
- References
- 120
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.